Faced with a new disease such as COVID-19, we need to be able to diagnose it, describe its prevalence in the population, map its time course and spatial distribution, learn about what treatments work, develop and test a vaccine, and communicate with decision-makers and the population. Each of these present challenging statistical issues. We describe how the UK mounted responses to these, including large scale prevalence surveys, and platform adaptive trials that informed policy and clinical practice and show how a rapid response is possible where the statistical community is well-prepared.
RSS North Eastern Local Group
For further information please contact Aamir Khan